Our news

  • In this instalment of the CIDG 'Meet the Editor' series, we talk with Professor George Rutherford. He has spent the last 18 years as Coordinating Editor of the Cochrane HIV/AIDS Group prior to its merger with the Cochrane Infectious Diseases Group (CIDG). He serves as a consultant to the World Health Organization (WHO) for systematic reviews...
    November 2 2017
  • What’s new!Please find details below on the latest submission to the Cochrane Database of Systematic Reviews Issue 10, 2017 (Reviews and protocols published 1 to 31 October) from the Cochrane Infectious Diseases Group.Review updateTickell-Painter M, Maayan N, Saunders R, Pace C, Sinclair D.  Mefloquine for preventing malaria during...
    October 31 2017
  • Cochrane Review looks at the effectiveness and side effects of mefloquineResearchers from LSTM Cochrane Infectious Diseases Group publish two systematic reviews this week about the safety of mefloquine (Lariam) for preventing malaria in travellers. “Mefloquine is at least as effective as other options” says Dr Tickell-Painter, the lead author...
    October 31 2017
  • Point-of-care rapid diagnostic tests (RDTs) which use a small amount of blood are available for infectious diseases, such as malaria and HIV, and make an important contribution to patient management. Cochrane Reviews of the accuracy of such tests have influenced WHO policy and, in May 2017, they were added to with a new Cochrane Diagnostic Test...
    October 23 2017
  • What’s new!Please find details below on the latest submission to the Cochrane Database of Systematic Reviews Issue 9, 2017 (Reviews and protocols published 1 to 30 September) from the Cochrane Infectious Diseases Group.Two review updatesWiysonge CS, Ndze VN, Kongnyuy EJ, Shey MS. Vitamin A supplements for reducing mother-to-child HIV transmission...
    October 19 2017
  • The Cochrane Infectious Diseases Group (CIDG) is one of the first Cochrane Editorial Groups to be established, which has a strong record in high quality reviews in malaria, tuberculosis, tropical and other infectious diseases, and are now responsible for the HIV/AIDS portfolio. The CIDG is a partner within the Effective Health Care...
    October 13 2017
  • Researchers from South Africa and Canada have carried out a Cochrane review update to assess the safety and effectiveness of corticosteroids for treating tuberculous pericarditis.Tuberculosis (TB) infection of the pericardium, the membrane around the heart, is not common but can restrict the function of the heart and is fatal in some cases....
    September 14 2017
  • In this instalment of the 'Meet the Editor' series, we talk with CIDG Editor Dr Michael Eisenhut. Dr Eisenhut has published papers on a broad range of subjects, including tuberculosis, malaria, HIV, respiratory syncytial virus bronchiolitis, the pathophysiology of inflammation, sepsis, and meningitis, and several systematic reviews. He is...
    September 6 2017
  • What’s new!Please find details below on the latest submission to the Cochrane Database of Systematic Reviews Issue 8, 2017 (Reviews and protocols published 1 to 31 August 2017) from the Cochrane Infectious Diseases Group.Four new protocolsWeeratunga P, Rodrigo C, Fernando SD, Rajapakse S. Control methods for Aedes...
    September 6 2017
  • The Cochrane Infectious Diseases Group (CIDG) editorial base said a fond farewell to Anne-Marie Stephani on Friday 25th August. Anne-Marie joined the CIDG as Managing Editor in 2009 and has been instrumental in assuring rigorous, fair, and prompt editorial management of the CIDG; in maintaining excellent communication with editors...
    August 31 2017

Pages

Subscribe to Our news